CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 103 enrolled
Drug / intervention
Breathing retraining +2 morebehavioral
Likely dose
Not stated in record
Key inclusion· 4
  • Age ≥40 years
  • FEV1 ≤70% predicted
  • FEV1/FVC ratio <70%
  • RV/TLC >120% (air trapping/hyperinflation)
Key exclusion· 6
  • Respiratory infection or exacerbation within 4 weeks
  • Exercise-limiting heart disease
  • Primary asthma diagnosis
  • NYHA Class III–IV congestive heart failure

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00123422
NCT00123422N/ACompleted

Innovation Methods to Augment Pulmonary Rehabilitation

US Department of Veterans Affairs·interventional·Posted Jul 22, 2005·Updated Oct 16, 2014

In Brief

A clinical study evaluating Breathing retraining, Heliox, and 1 other intervention for Pulmonary Disease and Pulmonary Emphysema. Completed, enrolled 103 participants across 1 site.

Detailed Summary

The purpose of this study was to compare the effect of exercise treatment combined with breathing retraining (a computerized feedback program), with exercise treatment combined with heliox (a helium and oxygen combination), with exercise only in patients with moderate to severe chronic obstructive pulmonary disease. This was an 8-week intervention study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 22, 2005
Enrollment StartOct 1, 2005
Primary CompletionAug 1, 2009
Study CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 20.9 years ago

Interventions

Breathing retrainingbehavioral

exercise training with computerized training program

Helioxbehavioral

exercise training with a helium oxygen combination

Exercisebehavioral

exercise training